Cause-specific number of incident cancer and age–sex–calendar-year-standardised incidence ratio of study cohort
| Cancer site and diagnostic code (ICD-9-CM code) | No of incidences | Standardised incidence ratio | ||
| n | Percentage | Estimate | 95% CI | |
| All cancers | 279 | 100.0 | 80 | 71 to 90 |
| Tongue (141) | 2 | 0.7 | 30 | 3 to 107 |
| Gum (143) | 1 | 0.4 | 75 | 13 to 419 |
| Other and unspecified parts of mouth (145) | 2 | 0.7 | 24 | 7 to 87 |
| Nasopharynx (147) | 10 | 3.6 | 94 | 45 to 174 |
| Other and ill-defined sites within the lip, oral cavity and pharynx (149) | 2 | 0.7 | 812 | 91 to 2932 |
| Oesophagus (150) | 4 | 1.4 | 60 | 16 to 153 |
| Stomach (151) | 22 | 7.9 | 96 | 60 to 146 |
| Small intestine, including duodenum (152) | 1 | 0.4 | 71 | 13 to 396 |
| Colon (153) | 30 | 10.8 | 133 | 90 to 190 |
| Rectum, rectosigmoid junction and anus (154) | 8 | 2.9 | 45 | 19 to 88 |
| Liver and intrahepatic bile ducts (155) | 64 | 22.9 | 151 | 116 to 192 |
| Gall bladder and extrahepatic bile ducts (156) | 1 | 0.4 | 29 | 5 to 163 |
| Pancreas (157) | 7 | 2.5 | 136 | 54 to 279 |
| Nasal cavities, middle ear and accessory sinuses (160) | 2 | 0.7 | 167 | 19 to 604 |
| Larynx (161) | 4 | 1.4 | 166 | 45 to 426 |
| Trachea, bronchus and lung (162) | 35 | 12.5 | 97 | 68 to 135 |
| Thymus, heart, and mediastinum (164) | 1 | 0.4 | 98 | 18 to 544 |
| Connective and other soft tissue (171) | 2 | 0.7 | 91 | 25 to 328 |
| Skin (172-173) | 5 | 1.8 | 45 | 15 to 106 |
| Female breast (174)* | 3 | 1.1 | 30 | 9 to 87 |
| Uterus, part unspecified (179)* | 1 | 0.4 | 284 | 37 to 2179 |
| Cervix uteri (180)* | 1 | 0.4 | 10 | 2 to 54 |
| Ovary and other uterine adnexa (183)* | 1 | 0.4 | 75 | 13 to 417 |
| Prostate (185)† | 12 | 4.3 | 63 | 33 to 111 |
| Testis (186)† | 1 | 0.4 | 117 | 21 to 649 |
| Bladder (188) | 25 | 9.0 | 259 | 167 to 382 |
| Kidney and other and unspecified urinary organs (189) | 11 | 3.9 | 157 | 78 to 281 |
| Brain (191) | 4 | 1.4 | 129 | 35 to 329 |
| Thyroid gland (193) | 5 | 1.8 | 62 | 20 to 144 |
| Other and ill-defined sites (195) | 1 | 0.4 | 330 | 59 to 1836 |
| Without specification of site (199) | 6 | 2.2 | 92 | 34 to 201 |
| Lymphatic and haematopoietic tissue (200-208) | 5 | 1.8 | 70 | 22 to 163 |